|
1
|
Leveque N, Brixi-Benmansour H, Reig T,
Renois F, Talmud D, Brodard V, Coste JF, De Champs C, Andréoletti L
and Diebold MD: Low frequency of cytomegalovirus infection during
exacerbations of inflammatory bowel diseases. J Med Virol.
82:1694–1700. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Da Silva BC, Lyra AC, Rocha R and Santana
GO: Epidemiology, demographic characteristics and prognostic
predictors of ulcerative colitis. World J Gastroenterol.
20:9458–9467. 2014.PubMed/NCBI
|
|
3
|
Lee KM and Lee JM: Crohn's disease in
Korea: Past, present, and future. Korean J Intern Med. 29:558–570.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
D'Ovidio V, Vernia P, Gentile G,
Capobianchi A, Marcheggiano A, Viscido A, Martino P and Caprilli R:
Cytomegalovirus infection in inflammatory bowel disease patients
undergoing anti-TNFalpha therapy. J Clin Virol. 43:180–183. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lichtenstein GR, Rutgeerts P, Sandborn WJ,
Sands BE, Diamond RH, Blank M, Montello J, Tang L, Cornillie F and
Colombel JF: A pooled analysis of infections, malignancy, and
mortality in infliximab- and immunomodulator-treated adult patients
with inflammatory bowel disease. Am J Gastroenterol. 107:1051–1063.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Delvincourt M, Lopez A, Pillet S, Bourrier
A, Seksik P, Cosnes J, Carrat F, Gozlan J, Beaugerie L, Roblin X,
et al: The impact of cytomegalovirus reactivation and its treatment
on the course of inflammatory bowel disease. Aliment Pharmacol
Ther. 39:712–720. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jones A, McCurdy JD, Loftus EV Jr,
Bruining DH, Enders FT, Killian JM and Smyrk TC: Effects of
antiviral therapy for patients with inflammatory bowel disease and
a positive intestinal biopsy for cytomegalovirus. Clin
Gastroenterol Hepatol. 13:949–955. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McCurdy JD, Jones A, Enders FT, et al: A
model for identifying cytomegalovirus in patients with inflammatory
bowel disease. Clin Gastroenterol Hepatol. 13:131–137; quiz e7.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garrido E, Carrera E, Manzano R and
Lopez-Sanroman A: Clinical significance of cytomegalovirus
infection in patients with inflammatory bowel disease. World J
Gastroenterol. 19:17–25. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim JJ, Simpson N, Klipfel N, Debose R,
Barr N and Laine L: Cytomegalovirus infection in patients with
active inflammatory bowel disease. Dig Dis Sci. 55:1059–1065. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nowacki TM, Bettenworth D, Ross M,
Heidemann J, Lehmann PV and Lügering A: Cytomegalovirus
(CMV)-specific perforin and granzyme B ELISPOT assays detect
reactivation of CMV infection in inflammatory bowel disease. Cells.
1:35–50. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fukuchi T, Nakase H, Matsuura M, Yoshino
T, Toyonaga T, Ohmori K, Ubukata S, Ueda A, Eguchi T, Yamashita H,
et al: Effect of intensive granulocyte and monocyte adsorptive
apheresis in patients with ulcerative colitis positive for
cytomegalovirus. J Crohns Colitis. 7:803–811. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iida T, Ikeya K, Watanabe F, Abe J,
Maruyama Y, Ohata A, Teruyuki S, Sugimoto K and Hanai H: Looking
for endoscopic features of cytomegalovirus colitis: A study of 187
patients with active ulcerative colitis, positive and negative for
cytomegalovirus. Inflamm Bowel Dis. 19:1156–1163. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dubinsky M and Braun J: Diagnostic and
prognostic microbial biomarkers in inflammatory bowel diseases.
Gastroenterology. 149:1265.e3–1274.e3. 2015. View Article : Google Scholar
|
|
15
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen H, Manning AK and Dupuis J: A method
of moments estimator for random effect multivariate meta-analysis.
Biometrics. 68:1278–1284. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zintzaras E and Ioannidis JP: HEGESMA:
Genome search meta-analysis and heterogeneity testing.
Bioinformatics. 21:3672–3673. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song F and Gilbody S: Bias in
meta-analysis detected by a simple, graphical test. Increase in
studies of publication bias coincided with increasing use of
meta-analysis. BMJ. 316:4711998.PubMed/NCBI
|
|
19
|
Peters JL, Sutton AJ, Jones DR, Abrams KR
and Rushton L: Comparison of two methods to detect publication bias
in meta-analysis. JAMA. 295:676–680. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kishore J, Ghoshal U, Ghoshal UC,
Krishnani N, Kumar S, Singh M and Ayyagari A: Infection with
cytomegalovirus in patients with inflammatory bowel disease:
Prevalence, clinical significance and outcome. J Med Microbiol.
53:1155–1160. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cottone M, Pietrosi G, Martorana G, Casà
A, Pecoraro G, Oliva L, Orlando A, Rosselli M, Rizzo A and Pagliaro
L: Prevalence of cytomegalovirus infection in severe refractory
ulcerative and Crohn's colitis. Am J Gastroenterol. 96:773–775.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yoshino T, Nakase H, Ueno S, Uza N, Inoue
S, Mikami S, Matsuura M, Ohmori K, Sakurai T, Nagayama S, et al:
Usefulness of quantitative real-time PCR assay for early detection
of cytomegalovirus infection in patients with ulcerative colitis
refractory to immunosuppressive therapies. Inflamm Bowel Dis.
13:1516–1521. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao K, Li ZM, Zuo YN, Xie ZX, Li LK,
Zhang B and Peng D: Correlation of cytomegalovirus infection in the
intestine of patients with inflammatory bowel disease. Zhong Guo Yi
Yao Dao Kan. 13:1863–1865. 2011.(In Chinese).
|
|
24
|
Miller-Kittrell M and Sparer TE: Feeling
manipulated: Cytomegalovirus immune manipulation. Virol J. 6:42009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pillet S, Pozzetto B, Jarlot C, Paul S and
Roblin X: Management of cytomegalovirus infection in inflammatory
bowel diseases. Dig Liver Dis. 44:541–548. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maconi G, Lombardini M, Furfaro F, Bezzio
C, Zerbi P and Ardizzone S: Long-term outcome of inflammatory bowel
diseases with cytomegalovirus colitis: Effect of antiviral
treatment. Eur J Gastroenterol Hepatol. 26:1146–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Osaki R, Andoh A, Tsujikawa T, Ogawa A,
Koizumi Y, Nakahara T, Hata K, Sasaki M, Saito Y and Fujiyama Y:
Acute cytomegalovirus infection superimposed on
corticosteroid-naïve ulcerative colitis. Intern Med. 47:1341–1344.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Domenech E, Vega R, Ojanguren I, Hernández
A, Garcia-Planella E, Bernal I, Rosinach M, Boix J, Cabré E and
Gassull MA: Cytomegalovirus infection in ulcerative colitis: A
prospective, comparative study on prevalence and diagnostic
strategy. Inflamm Bowel Dis. 14:1373–1379. 2008. View Article : Google Scholar : PubMed/NCBI
|
